View in EDS

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.

Saved in:
Bibliographic Details
Title: Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
Authors: Bergmann L; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. Electronic address: l.bergmann@em.uni-frankfurt.de., Albiges L; Institut Gustave Roussy, Paris, France., Ahrens M; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany., Gross-Goupil M; Medical Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Boleti E; Royal Free London NHS Foundation Trust, London, UK., Gravis G; Institut Paoli-Calmettes, Department of Medical Oncology, Aix Marseille Univ, INSERM, CNRS, CRCM, Immunity and Cancer Team, Marseille, France., Fléchon A; Centre Léon Bérard, Lyon, France., Grimm MO; Jena University Hospital, Department of Urology and Comprehensive Cancer Center Central Germany, Jena, Germany., Bedke J; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany; Department of Urology & Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany., Barthélémy P; Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Castellano D; Hospital Universitario, Madrid, Spain., Mellado B; Hospital Clinic de Barcelona, Barcelona, Spain., Ivanyi P; Medical School, Department of Hematology and Oncology, Hanover, Germany., Rottey S; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium., Flörcken A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin, Germany., Suarez C; Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Maroto P; Sant Pau Hospital (Hospital de la Santa Creu i Sant Pau), Barcelona, Spain., Grünwald V; Clinic for Urology and Clinic for Medical Oncology, University Hospital, Essen, Germany., Oosting SF; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Kopecky J; Faculty Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Zschäbitz S; University Hospital, NCT Heidelberg, Heidelberg, Germany., Boegemann M; University Hospital Münster, Clinic for Urology, Münster, Germany., Buchler T; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic., Niegisch G; Department of Urology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Goebell PJ; Erlangen University Hospital, Department of Urology and Pediatric Urology, Erlangen, Germany., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Joly F; Centre Régional de Lutte contre le Cancer François Baclesse, Caen, France., Priou F; Hospital Center Departmental De Vendée, La-Roche-sur-Yon, France., Retz M; Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany., Siemer S; Department of Urology, Saarland University, Homburg/Saar, Germany., Zimmermann U; University Medical Center Greifswald, Clinic for Urology, Greifswald, Germany., Deckbar D; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany., Burkholder I; Department of Health Sciences, University of Applied Sciences, Fulda, Germany., Hartmann A; Institute of Pathology University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen EMN (CCC ER-ERM), Erlangen, Germany., Haanen JB; Netherlands Cancer Institute, Amsterdam, the Netherlands.
Corporate Authors: Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN)
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Jul; Vol. 36 (7), pp. 796-806. Date of Electronic Publication: 2025 Apr 01.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Comparative Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40180121
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bergmann+L%22">Bergmann L</searchLink>; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. Electronic address: l.bergmann@em.uni-frankfurt.de.<br /><searchLink fieldCode="AU" term="%22Albiges+L%22">Albiges L</searchLink>; Institut Gustave Roussy, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ahrens+M%22">Ahrens M</searchLink>; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Gross-Goupil+M%22">Gross-Goupil M</searchLink>; Medical Oncology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Boleti+E%22">Boleti E</searchLink>; Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Gravis+G%22">Gravis G</searchLink>; Institut Paoli-Calmettes, Department of Medical Oncology, Aix Marseille Univ, INSERM, CNRS, CRCM, Immunity and Cancer Team, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Fléchon+A%22">Fléchon A</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Grimm+MO%22">Grimm MO</searchLink>; Jena University Hospital, Department of Urology and Comprehensive Cancer Center Central Germany, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Bedke+J%22">Bedke J</searchLink>; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany; Department of Urology & Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Barthélémy+P%22">Barthélémy P</searchLink>; Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Castellano+D%22">Castellano D</searchLink>; Hospital Universitario, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mellado+B%22">Mellado B</searchLink>; Hospital Clinic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ivanyi+P%22">Ivanyi P</searchLink>; Medical School, Department of Hematology and Oncology, Hanover, Germany.<br /><searchLink fieldCode="AU" term="%22Rottey+S%22">Rottey S</searchLink>; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Flörcken+A%22">Flörcken A</searchLink>; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Suarez+C%22">Suarez C</searchLink>; Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Maroto+P%22">Maroto P</searchLink>; Sant Pau Hospital (Hospital de la Santa Creu i Sant Pau), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Grünwald+V%22">Grünwald V</searchLink>; Clinic for Urology and Clinic for Medical Oncology, University Hospital, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Oosting+SF%22">Oosting SF</searchLink>; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kopecky+J%22">Kopecky J</searchLink>; Faculty Hospital Hradec Kralove, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Zschäbitz+S%22">Zschäbitz S</searchLink>; University Hospital, NCT Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Boegemann+M%22">Boegemann M</searchLink>; University Hospital Münster, Clinic for Urology, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Buchler+T%22">Buchler T</searchLink>; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Niegisch+G%22">Niegisch G</searchLink>; Department of Urology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Goebell+PJ%22">Goebell PJ</searchLink>; Erlangen University Hospital, Department of Urology and Pediatric Urology, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Waddell+T%22">Waddell T</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Joly+F%22">Joly F</searchLink>; Centre Régional de Lutte contre le Cancer François Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Priou+F%22">Priou F</searchLink>; Hospital Center Departmental De Vendée, La-Roche-sur-Yon, France.<br /><searchLink fieldCode="AU" term="%22Retz+M%22">Retz M</searchLink>; Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Siemer+S%22">Siemer S</searchLink>; Department of Urology, Saarland University, Homburg/Saar, Germany.<br /><searchLink fieldCode="AU" term="%22Zimmermann+U%22">Zimmermann U</searchLink>; University Medical Center Greifswald, Clinic for Urology, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Deckbar+D%22">Deckbar D</searchLink>; Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Burkholder+I%22">Burkholder I</searchLink>; Department of Health Sciences, University of Applied Sciences, Fulda, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+A%22">Hartmann A</searchLink>; Institute of Pathology University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen EMN (CCC ER-ERM), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Haanen+JB%22">Haanen JB</searchLink>; Netherlands Cancer Institute, Amsterdam, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Interdisciplinary+Renal+Cell+Carcinoma+Working+Group+of+the+DKG+%28IAGN%29%22">Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2025 Jul; Vol. 36 (7), pp. 796-806. <i>Date of Electronic Publication: </i>2025 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40180121
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.03.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 796
    Titles:
      – TitleFull: Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bergmann L
      – PersonEntity:
          Name:
            NameFull: Albiges L
      – PersonEntity:
          Name:
            NameFull: Ahrens M
      – PersonEntity:
          Name:
            NameFull: Gross-Goupil M
      – PersonEntity:
          Name:
            NameFull: Boleti E
      – PersonEntity:
          Name:
            NameFull: Gravis G
      – PersonEntity:
          Name:
            NameFull: Fléchon A
      – PersonEntity:
          Name:
            NameFull: Grimm MO
      – PersonEntity:
          Name:
            NameFull: Bedke J
      – PersonEntity:
          Name:
            NameFull: Barthélémy P
      – PersonEntity:
          Name:
            NameFull: Castellano D
      – PersonEntity:
          Name:
            NameFull: Mellado B
      – PersonEntity:
          Name:
            NameFull: Ivanyi P
      – PersonEntity:
          Name:
            NameFull: Rottey S
      – PersonEntity:
          Name:
            NameFull: Flörcken A
      – PersonEntity:
          Name:
            NameFull: Suarez C
      – PersonEntity:
          Name:
            NameFull: Maroto P
      – PersonEntity:
          Name:
            NameFull: Grünwald V
      – PersonEntity:
          Name:
            NameFull: Oosting SF
      – PersonEntity:
          Name:
            NameFull: Kopecky J
      – PersonEntity:
          Name:
            NameFull: Zschäbitz S
      – PersonEntity:
          Name:
            NameFull: Boegemann M
      – PersonEntity:
          Name:
            NameFull: Buchler T
      – PersonEntity:
          Name:
            NameFull: Niegisch G
      – PersonEntity:
          Name:
            NameFull: Goebell PJ
      – PersonEntity:
          Name:
            NameFull: Waddell T
      – PersonEntity:
          Name:
            NameFull: Joly F
      – PersonEntity:
          Name:
            NameFull: Priou F
      – PersonEntity:
          Name:
            NameFull: Retz M
      – PersonEntity:
          Name:
            NameFull: Siemer S
      – PersonEntity:
          Name:
            NameFull: Zimmermann U
      – PersonEntity:
          Name:
            NameFull: Deckbar D
      – PersonEntity:
          Name:
            NameFull: Burkholder I
      – PersonEntity:
          Name:
            NameFull: Hartmann A
      – PersonEntity:
          Name:
            NameFull: Haanen JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1